220 related articles for article (PubMed ID: 35797002)
1. Evaluation of a Novel Αb Εxterno MicroShunt for the Treatment of Glaucoma.
Burgos-Blasco B; García-Feijóo J; Perucho-Gonzalez L; Güemes-Villahoz N; Morales-Fernandez L; Mendez-Hernández CD; Martinez de la Casa JM; Konstas AG
Adv Ther; 2022 Sep; 39(9):3916-3932. PubMed ID: 35797002
[TBL] [Abstract][Full Text] [Related]
2. Ab externo implantation of the MicroShunt, a poly (styrene-
Sadruddin O; Pinchuk L; Angeles R; Palmberg P
Eye Vis (Lond); 2019; 6():36. PubMed ID: 31807606
[TBL] [Abstract][Full Text] [Related]
3. The PreserFlo MicroShunt in the Context of Minimally Invasive Glaucoma Surgery: A Narrative Review.
Saeed E; Gołaszewska K; Dmuchowska DA; Zalewska R; Konopińska J
Int J Environ Res Public Health; 2023 Feb; 20(4):. PubMed ID: 36833599
[TBL] [Abstract][Full Text] [Related]
4. Which Patients Would Most Likely to Benefit: MIGS or MEGS, Which One Is It?
Sheheitli H; Tirpack AR; Parrish RK
Asia Pac J Ophthalmol (Phila); 2019; 8(6):436-440. PubMed ID: 31789645
[TBL] [Abstract][Full Text] [Related]
5. PreserFlo
Gambini G; Carlà MM; Giannuzzi F; Caporossi T; De Vico U; Savastano A; Baldascino A; Rizzo C; Kilian R; Caporossi A; Rizzo S
Vision (Basel); 2022 Feb; 6(1):. PubMed ID: 35225971
[TBL] [Abstract][Full Text] [Related]
6. Subconjunctival filtration in evolution: current evidence on MicroShunt implantation for treating patients with glaucoma.
Ahmed IIK; Sadruddin O; Panarelli JF
Eye Vis (Lond); 2023 Mar; 10(1):10. PubMed ID: 36859515
[TBL] [Abstract][Full Text] [Related]
7. PreserFlo MicroShunt® exposure: a case series.
Bunod R; Robin M; Buffault J; Keilani C; Labbé A; Baudouin C
BMC Ophthalmol; 2021 Jul; 21(1):273. PubMed ID: 34246229
[TBL] [Abstract][Full Text] [Related]
8. Inter-eye relationship of intraocular pressure change after unilateral trabeculectomy, filtering canaloplasty, or PreserFlo™ microshunt implantation.
Aghayeva FA; Chronopoulos P; Schuster AK; Pfeiffer N; Hoffmann EM
Graefes Arch Clin Exp Ophthalmol; 2021 Oct; 259(10):3045-3053. PubMed ID: 33963917
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of MicroShunt in Patients with Primary Open-Angle and Pseudoexfoliative Glaucoma: A Retrospective European Multicenter Study.
Fea AM; Laffi GL; Martini E; Economou MA; Caselgrandi P; Sacchi M; Au L
Ophthalmol Glaucoma; 2022; 5(2):210-218. PubMed ID: 34478904
[TBL] [Abstract][Full Text] [Related]
10. Comparing the safety and efficacy of Preserflo Microshunt implantation and trabeculectomy for glaucoma: A systematic review and meta-analysis.
Khan A; Khan AU
Acta Ophthalmol; 2024 Jun; 102(4):e443-e451. PubMed ID: 38376121
[TBL] [Abstract][Full Text] [Related]
11. Ab-Externo MicroShunt versus Trabeculectomy in Primary Open-Angle Glaucoma: One-Year Results from a 2-Year Randomized, Multicenter Study.
Baker ND; Barnebey HS; Moster MR; Stiles MC; Vold SD; Khatana AK; Flowers BE; Grover DS; Strouthidis NG; Panarelli JF;
Ophthalmology; 2021 Dec; 128(12):1710-1721. PubMed ID: 34051211
[TBL] [Abstract][Full Text] [Related]
12. PRESERFLO™ MicroShunt versus trabeculectomy: first results on efficacy and safety.
Pillunat KR; Herber R; Haase MA; Jamke M; Jasper CS; Pillunat LE
Acta Ophthalmol; 2022 May; 100(3):e779-e790. PubMed ID: 34331505
[TBL] [Abstract][Full Text] [Related]
13. XEN
Scheres LMJ; Kujovic-Aleksov S; Ramdas WD; de Crom RMPC; Roelofs LCG; Berendschot TTJM; Webers CAB; Beckers HJM
Acta Ophthalmol; 2021 May; 99(3):e433-e440. PubMed ID: 32909682
[TBL] [Abstract][Full Text] [Related]
14. Subconjunctival microinvasive glaucoma surgeries: an update on the Xen gel stent and the PreserFlo MicroShunt.
Do AT; Parikh H; Panarelli JF
Curr Opin Ophthalmol; 2020 Mar; 31(2):132-138. PubMed ID: 31922979
[TBL] [Abstract][Full Text] [Related]
15. Intraocular Pressure-Lowering Effects of Trabeculectomy Versus MicroShunt Insertion in Rabbit Eyes.
Fujimoto T; Nakashima KI; Watanabe-Kitamura F; Watanabe T; Nakamura K; Maki K; Shimazaki A; Kato M; Tanihara H; Inoue T
Transl Vis Sci Technol; 2021 Aug; 10(9):9. PubMed ID: 34357381
[TBL] [Abstract][Full Text] [Related]
16. Ab externo device for the treatment of glaucoma: direct flow from the anterior chamber to the ocular surface.
Schultz T; Schojai M; Kersten-Gomez I; Matthias E; Boecker J; Dick HB
J Cataract Refract Surg; 2020 Jul; 46(7):941-943. PubMed ID: 32271273
[TBL] [Abstract][Full Text] [Related]
17. Minimally Invasive Glaucoma Surgery: Latest Developments and Future Challenges.
Chan PPM; Larson MD; Dickerson JE; Mercieca K; Koh VTC; Lim R; Leung EHY; Samuelson TW; Larsen CL; Harvey A; Töteberg-Harms M; Meier-Gibbons F; Shu-Wen Chan N; Sy JB; Mansouri K; Zhang X; Lam DSC
Asia Pac J Ophthalmol (Phila); 2023 Nov-Dec 01; 12(6):537-564. PubMed ID: 38079242
[TBL] [Abstract][Full Text] [Related]
18. [Comparison of new and old procedures in glaucoma surgery : Trabeculectomy, Preserflo and XEN].
Prokosch V; Dietlein T; Pfeiffer N
Ophthalmologie; 2023 Apr; 120(4):350-357. PubMed ID: 37052708
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness and cost-effectiveness of MicroShunt implantation versus standard trabeculectomy for open-angle glaucoma (a SIGHT study): study protocol of a multicentre randomised controlled trial.
Scheres LMJ; van den Biggelaar FJHM; Winkens B; Kujovic-Aleksov S; Müskens RPHM; de Waard PWT; de Crom RMPC; Ernest PJG; Pijl BJ; Ramdas WD; van Rijn LJ; Tan A; Dirksen CD; Beckers HJM
BMC Ophthalmol; 2023 Jan; 23(1):43. PubMed ID: 36721130
[TBL] [Abstract][Full Text] [Related]
20. Review of the Xen Gel Stent and InnFocus MicroShunt.
Green W; Lind JT; Sheybani A
Curr Opin Ophthalmol; 2018 Mar; 29(2):162-170. PubMed ID: 29319544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
